Polymeric bile acid sequestrants: Review of design, in vitro binding activities, and hypocholesterolemic effects

被引:29
作者
Hermankova, Eva [1 ]
Zak, Aleg [2 ]
Polakova, Lenka [1 ]
Hobzova, Radka [1 ]
Hromadka, Robert [3 ]
Sirc, Jakub [1 ]
机构
[1] Czech Acad Sci, Inst Macromol Chem, Heyrovsky Sq 2, CZ-16206 Prague, Czech Republic
[2] Charles Univ Prague, Fac Med 1, Dept Med 4, U Nemocnice 2, CZ-12808 Prague, Czech Republic
[3] C2P Sro, Ctr Res & Dev, Chlumec Nad Cidlinou, Czech Republic
关键词
Review; Bile acid sequestrant; Pleiotropic effect; Cholestyramine; Cyclodextrin; Molecular imprinting; AMPHIPHILIC BLOCK-COPOLYMERS; BETA-CYCLODEXTRINS INFLUENCE; CROSS-LINKED POLYMERS; DMP; 504; COLESEVELAM HYDROCHLORIDE; COMBINATION THERAPY; CHOLIC-ACID; F; 97426-A; CHOLESTEROL; COMPLEXATION;
D O I
10.1016/j.ejmech.2017.12.015
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Polymeric bile acid sequestrants (BAS) have recently attracted much attention as lipid-lowering agents. These non-absorbable materials specifically bind bile acids (BAs) in the intestine, preventing bile acid (BA) reabsorption into the blood through enterohepatic circulation. Therefore, it is important to understand the structure-property relationships between the polymer sequestrant and its ability to bind specific BAs molecules. In this review, we describe pleiotropic effects of bile acids, and we focus on BAS with various molecular architectures that result in different mechanisms of BA sequestration. Here, we present 1) amphiphilic polymers based on poly(meth)acrylates, poly(meth)acrylamides, polyalkylamines and polyallylamines containing quaternary ammonium groups, 2) cyclodextrins, and 3) BAS prepared via molecular imprinting methods. The synthetic approaches leading to individual BAS preparation, as well as results of their in vitro BA binding activities and in vivo lipid-lowering activities, are discussed. (C) 2017 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:300 / 317
页数:18
相关论文
共 97 条
[1]   Colesevelam hydrochloride: A novel bile acid-binding resin [J].
Aldridge, MA ;
Ito, MK .
ANNALS OF PHARMACOTHERAPY, 2001, 35 (7-8) :898-907
[2]   Cyclodextrin- Mediated Hierarchical Self- Assembly and Its Potential in Drug Delivery Applications [J].
Antoniuk, Iurii ;
Amiel, Catherine .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 105 (09) :2570-2588
[3]   Potential Use of Cyclodextrins as Drug Carriers and Active Pharmaceutical Ingredients [J].
Arima, Hidetoshi ;
Motoyama, Keiichi ;
Higashi, Taishi .
CHEMICAL & PHARMACEUTICAL BULLETIN, 2017, 65 (04) :341-348
[4]   Functionalized β-cyclodextrin polymers for the sorption of bile salts [J].
Baille, WE ;
Huang, WQ ;
Nichifor, M ;
Zhu, XX .
JOURNAL OF MACROMOLECULAR SCIENCE-PURE AND APPLIED CHEMISTRY, 2000, 37 (07) :677-690
[5]   Bile acids: From digestion to cancers [J].
Baptissart, Marine ;
Vega, Aurelie ;
Maqdasy, Salwan ;
Caira, Francoise ;
Baron, Silvere ;
Lobaccaro, Jean-Marc A. ;
Volle, David H. .
BIOCHIMIE, 2013, 95 (03) :504-517
[6]   SK&F 97426-A: A novel bile acid sequestrant with higher affinities and slower dissociation rates for bile acids in vitro than cholestyramine [J].
Benson, GM ;
Alston, DR ;
Hickey, DMB ;
JaxaChamiec, AA ;
Whittaker, CM ;
Haynes, C ;
Glen, A ;
Blanchard, S ;
Cresswell, SR ;
Suckling, KE .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1997, 86 (01) :76-81
[7]   SK-AND-F 97426-A A MORE POTENT BILE-ACID SEQUESTRANT AND HYPOCHOLESTEROLEMIC AGENT THAN CHOLESTYRAMINE IN THE HAMSTER [J].
BENSON, GM ;
ALSTON, DR ;
BOND, BC ;
GEE, AN ;
GLEN, A ;
HAYNES, C ;
HICKEY, DMB ;
IQBAL, S ;
JACKSON, B ;
JAXACHAMIEC, AA ;
JOHNSON, MR ;
ROBERTS, MG ;
SLINGSBY, BP ;
WHITTAKER, CM ;
SUCKLING, KE .
ATHEROSCLEROSIS, 1993, 101 (01) :51-60
[8]   INVITRO STUDIES TO INVESTIGATE THE REASONS FOR THE LOW POTENCY OF CHOLESTYRAMINE AND COLESTIPOL [J].
BENSON, GM ;
HAYNES, C ;
BLANCHARD, S ;
ELLIS, D .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1993, 82 (01) :80-86
[9]  
Boehler N, 1999, J LIPID RES, V40, P726
[10]  
Buschmann HJ, 2002, J COSMET SCI, V53, P185